FDA Inspection
Winder Laboratories, LLCWinder Laboratories, LLC – FDA Inspection, Jun 9, 2017
Record Details
This FDA Inspection record concerns Winder Laboratories, LLC, with an inspection on June 9, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Kara D. Dobbin (Issuing Officer)
View Company Profile
ID · c673cea2-5385-499c-a139-2859a53c3aeb
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1017551
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Winder Laboratories, LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2025 | OAI | Atlanta District Office | Drug Quality Assurance |
| February 5, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 3, 2023 | VAI | Atlanta District Office | |
| March 13, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Winder Laboratories, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.